Mural Oncology PLC (MURA)
3.77
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
3.75
-0.02
(-0.53%)
After-Hours: 20:00
Mural Oncology Cash from Investing (TTM): -127.59M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -127.59M |
Date | Value |
---|---|
December 31, 2023 | -3.452M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-127.59M
Minimum
Mar 2024
-3.452M
Maximum
Dec 2023
-65.52M
Average
-65.52M
Median
Cash from Investing (TTM) Benchmarks
Amarin Corp PLC | 22.81M |
Jazz Pharmaceuticals PLC | -430.14M |
Prothena Corp PLC | -2.828M |
Iterum Therapeutics PLC | 25.44M |
GH Research PLC | 8.71M |